Henry H. Armstrong Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237K Hold
1,843
0.02% 58
2026
Q1
$222K Sell
1,843
-130
-7% -$15K 0.02% 58
2025
Q4
$208K Buy
+1,973
New +$185K 0.02% 61
2025
Q1
Sell
-2,222
Closed -$221K 60
2024
Q4
$221K Sell
2,222
-830
-27% -$85.6K 0.02% 55
2024
Q3
$347K Sell
3,052
-310
-9% -$36.8K 0.03% 54
2024
Q2
$416K Buy
3,362
+139
+4% +$17.9K 0.04% 48
2024
Q1
$425K Buy
3,223
+192
+6% +$23.7K 0.04% 45
2023
Q4
$330K Hold
3,031
0.04% 47
2023
Q3
$312K Hold
3,031
0.04% 47
2023
Q2
$350K Hold
3,031
0.04% 47
2023
Q1
$322K Buy
3,031
+56
+2% +$6.05K 0.04% 49
2022
Q4
$330K Buy
2,975
+180
+6% +$18.4K 0.04% 48
2022
Q3
$241K Hold
2,795
0.03% 57
2022
Q2
$255K Hold
2,795
0.03% 55
2022
Q1
$229K Hold
2,795
0.02% 60
2021
Q4
$214K Hold
2,795
0.02% 59
2021
Q3
$210K Buy
+2,795
New +$213K 0.02% 59
2021
Q1
Sell
-2,667
Closed -$208K 61
2020
Q4
$208K Hold
2,667
0.03% 60
2020
Q3
$211K Buy
+2,667
New +$209K 0.03% 56

Other funds holding MRK

Henry H. Armstrong Associates's MRK Position: Q2 2026 in Review

Henry H. Armstrong Associates held its Merck (MRK) position steady in Q2 2026 at 1,843 shares worth $237K. The position accounts for 0.02% of the portfolio, ranked #58.

Henry H. Armstrong Associates first reported a position in MRK in Q3 2020 and has held it in 19 quarters since. The position peaked at $425K in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Henry H. Armstrong Associates held 1,843 shares of Merck worth $237K as of Q2 2026.
  • Henry H. Armstrong Associates left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.02% of Henry H. Armstrong Associates's portfolio in Q2 2026, its #58 holding.
  • Henry H. Armstrong Associates first reported a position in Merck in Q3 2020 and has held it in 19 quarters since.
  • Henry H. Armstrong Associates's Merck position peaked at $425K in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Henry H. Armstrong Associates's 13F filing for Q2 2026, filed 7 Jul 2026.